Bashan Dror
Protalix BioTherapeutics, Inc. · PRESIDENT AND CEO
Bashan Dror is listed in filings as PRESIDENT AND CEO at Protalix BioTherapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 23, 2025, including purchase activity. Recent filings connect the profile to Protalix BioTherapeutics, Inc. (PLX). The current snapshot covers public activity from Sep 4, 2025 to Dec 23, 2025. Reported amounts are shown as $101.4K to $557.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||